• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

德国黑森林地区伴发嗜铬细胞瘤的冯·希佩尔-林道(VHL)病:奠基者效应的证据

Von Hippel-Lindau (VHL) disease with pheochromocytoma in the Black Forest region of Germany: evidence for a founder effect.

作者信息

Brauch H, Kishida T, Glavac D, Chen F, Pausch F, Höfler H, Latif F, Lerman M I, Zbar B, Neumann H P

机构信息

Institute of Pathology, Technical University Munich, Germany.

出版信息

Hum Genet. 1995 May;95(5):551-6. doi: 10.1007/BF00223868.

DOI:10.1007/BF00223868
PMID:7759077
Abstract

We identified a germline missense mutation at nucleotide 505 (T to C) of the VHL tumor suppressor gene in 14, apparently unrelated, VHL type 2A families from the Black Forest region of Germany. This mutation was previously identified in two VHL 2A families living in Pennsylvania (USA). All affected individuals in the 16 families shared the same VHL haplotype indicating a founder effect. This missense mutation at codon 169 (Tyr to His) would probably cause an alteration in the structure of the putative VHL protein. The association of this distinct mutation with the pheochromocytoma phenotype in VHL may help to elucidate the genetic mechanism of carcinogenesis in this multi tumor cancer syndrome.

摘要

我们在来自德国黑森林地区的14个明显无亲缘关系的2A型冯希佩尔-林道综合征(VHL)家族中,鉴定出VHL肿瘤抑制基因第505位核苷酸(从T到C)的种系错义突变。此前在美国宾夕法尼亚州的两个2A型VHL家族中也发现了这种突变。这16个家族中的所有患病个体都共享相同的VHL单倍型,表明存在奠基者效应。这个位于第169位密码子(从酪氨酸到组氨酸)的错义突变可能会导致假定的VHL蛋白结构发生改变。这种独特的突变与VHL中的嗜铬细胞瘤表型之间的关联,可能有助于阐明这种多肿瘤癌症综合征的致癌遗传机制。

相似文献

1
Von Hippel-Lindau (VHL) disease with pheochromocytoma in the Black Forest region of Germany: evidence for a founder effect.德国黑森林地区伴发嗜铬细胞瘤的冯·希佩尔-林道(VHL)病:奠基者效应的证据
Hum Genet. 1995 May;95(5):551-6. doi: 10.1007/BF00223868.
2
Germline mutations in the von Hippel-Lindau disease tumor suppressor gene: correlations with phenotype.冯·希佩尔-林道病肿瘤抑制基因的种系突变:与表型的相关性。
Hum Mutat. 1995;5(1):66-75. doi: 10.1002/humu.1380050109.
3
Genotype-phenotype correlation in von Hippel-Lindau disease: identification of a mutation associated with VHL type 2A.冯·希佩尔-林道病的基因型-表型相关性:鉴定与2A型VHL相关的突变
J Med Genet. 1996 Aug;33(8):716-7. doi: 10.1136/jmg.33.8.716.
4
A novel von Hippel-Lindau point mutation presents as apparently sporadic pheochromocytoma.一种新的von Hippel-Lindau点突变表现为明显散发的嗜铬细胞瘤。
Cancer Invest. 2008 Jul;26(6):642-6. doi: 10.1080/07357900701802527.
5
Molecular characterization and ophthalmic investigation of a large family with type 2A Von Hippel-Lindau Disease.2A型冯·希佩尔-林道病一个大家族的分子特征及眼科研究
Arch Ophthalmol. 2001 Nov;119(11):1659-65. doi: 10.1001/archopht.119.11.1659.
6
Mutation screening of VHL gene in a family with malignant bilateral pheochromocytoma: from isolated familial pheochromocytoma to von Hippel-Lindau disease.VHL 基因突变筛查一家族性双侧嗜铬细胞瘤:从孤立性家族性嗜铬细胞瘤到 von Hippel-Lindau 病。
Fam Cancer. 2009;8(4):465-71. doi: 10.1007/s10689-009-9266-4. Epub 2009 Aug 1.
7
Consequences of direct genetic testing for germline mutations in the clinical management of families with multiple endocrine neoplasia, type II.针对II型多发性内分泌腺瘤病家族临床管理中种系突变进行直接基因检测的后果。
JAMA. 1995 Oct 11;274(14):1149-51.
8
Germline VHL gene mutations in Hungarian families with von Hippel-Lindau disease and patients with apparently sporadic unilateral pheochromocytomas.患有冯·希佩尔-林道病的匈牙利家族及明显散发的单侧嗜铬细胞瘤患者的种系VHL基因突变
Eur J Endocrinol. 2009 Sep;161(3):495-502. doi: 10.1530/EJE-09-0399. Epub 2009 Jul 2.
9
Molecular diagnosis of von Hippel-Lindau disease in a kindred with a predominance of familial phaeochromocytoma.以家族性嗜铬细胞瘤为主的一个家系中冯·希佩尔-林道病的分子诊断
Clin Endocrinol (Oxf). 1997 Mar;46(3):359-63. doi: 10.1046/j.1365-2265.1997.00149.x.
10
von Hippel-Lindau disease type 2A in a family with a duplicated 21-base-pair in-frame insertion mutation in the VHL gene.一个患有VHL基因21个碱基对框内重复插入突变的家族中的2A型希佩尔-林道病。
Graefes Arch Clin Exp Ophthalmol. 2003 Mar;241(3):241-4. doi: 10.1007/s00417-003-0631-y. Epub 2003 Feb 20.

引用本文的文献

1
Multi-Platform Curation in the Development of ACMG/AMP Specifications for Von Hippel Lindau (VHL) Disease.冯·希佩尔-林道(VHL)病的ACMG/AMP规范制定中的多平台管理
medRxiv. 2025 Aug 27:2025.08.25.25334371. doi: 10.1101/2025.08.25.25334371.
2
Genotype-specific neoplastic risk profiles in patients with VHL disease.VHL病患者的基因型特异性肿瘤风险概况。
Endocr Relat Cancer. 2025 Apr 28;32(5). doi: 10.1530/ERC-24-0260. Print 2025 May 1.
3
Characterization of the Pheochromocytoma-Predominant Subgroup of von Hippel-Lindau Disease.

本文引用的文献

1
LINDAU'S DISEASE. REVIEW OF THE LITERATURE AND STUDY OF A LARGE KINDRED.林道氏病。文献综述及一个大家系的研究
Am J Med. 1964 Apr;36:595-617. doi: 10.1016/0002-9343(64)90107-x.
2
Three polymorphic dinucleotide repeats near the von Hippel Lindau (VHL) disease gene on human chromosome 3: D3S587; D3S1317; D3S1435.人类3号染色体上靠近冯·希佩尔-林道(VHL)病基因的三个多态性二核苷酸重复序列:D3S587;D3S1317;D3S1435。
Hum Mol Genet. 1993 Aug;2(8):1326. doi: 10.1093/hmg/2.8.1326.
3
Three tetrameric repeat polymorphisms on human chromosome 3: D3S1349; D3S1350; D3S1351.
以嗜铬细胞瘤为主的冯·希佩尔-林道病亚组的特征
Urology. 2025 Jun;200:19-27. doi: 10.1016/j.urology.2025.03.006. Epub 2025 Mar 14.
4
The genetic differences between types 1 and 2 in von Hippel-Lindau syndrome: comprehensive meta-analysis.Ⅰ型和Ⅱ型 von Hippel-Lindau 综合征的基因差异:综合荟萃分析。
BMC Ophthalmol. 2024 Aug 13;24(1):343. doi: 10.1186/s12886-024-03597-1.
5
Hereditary Renal Cancer Syndromes.遗传性肾癌综合征。
Med Sci (Basel). 2024 Feb 18;12(1):12. doi: 10.3390/medsci12010012.
6
Hypoxia-inducible factor underlies von Hippel-Lindau disease stigmata.缺氧诱导因子是 von Hippel-Lindau 病特征的基础。
Elife. 2022 Aug 30;11:e80774. doi: 10.7554/eLife.80774.
7
Systematic Review: Incidence of Pheochromocytoma and Paraganglioma Over 70 Years.系统评价:70年间嗜铬细胞瘤和副神经节瘤的发病率
J Endocr Soc. 2022 Jul 3;6(9):bvac105. doi: 10.1210/jendso/bvac105. eCollection 2022 Sep 1.
8
Von Hippel-Lindau "Black Forest" mutation inherited in a large Chinese family.在中国一个大家庭中遗传性的希佩尔-林道“黑森林”突变。
Gland Surg. 2019 Aug;8(4):343-353. doi: 10.21037/gs.2019.08.03.
9
The Methods Employed in Mass Spectrometric Analysis of Posttranslational Modifications (PTMs) and Protein-Protein Interactions (PPIs).用于翻译后修饰(PTMs)和蛋白质-蛋白质相互作用(PPIs)的质谱分析方法。
Adv Exp Med Biol. 2019;1140:169-198. doi: 10.1007/978-3-030-15950-4_10.
10
Pedigree analysis, diagnosis and treatment in Von Hippel-Lindau syndrome: A report of three cases.冯·希佩尔-林道综合征的家系分析、诊断与治疗:三例报告
Oncol Lett. 2018 Apr;15(4):4882-4890. doi: 10.3892/ol.2018.7957. Epub 2018 Feb 5.
人类3号染色体上的三个四聚体重复多态性:D3S1349;D3S1350;D3S1351。
Hum Mol Genet. 1993 Jun;2(6):819. doi: 10.1093/hmg/2.6.819.
4
Frequent somatic mutations and loss of heterozygosity of the von Hippel-Lindau tumor suppressor gene in primary human renal cell carcinomas.原发性人类肾细胞癌中冯·希佩尔-林道肿瘤抑制基因的频繁体细胞突变和杂合性缺失
Cancer Res. 1994 Jun 1;54(11):2852-5.
5
Pheochromocytomas, multiple endocrine neoplasia type 2, and von Hippel-Lindau disease.嗜铬细胞瘤、2型多发性内分泌腺瘤病和冯·希佩尔-林道病。
N Engl J Med. 1993 Nov 18;329(21):1531-8. doi: 10.1056/NEJM199311183292103.
6
Somatic mutations of the von Hippel-Lindau tumor suppressor gene in sporadic central nervous system hemangioblastomas.散发性中枢神经系统血管母细胞瘤中冯·希佩尔-林道肿瘤抑制基因的体细胞突变。
Cancer Res. 1994 Sep 15;54(18):4845-7.
7
Identification of intragenic mutations in the von Hippel-Lindau disease tumour suppressor gene and correlation with disease phenotype.冯·希佩尔-林道病肿瘤抑制基因内基因突变的鉴定及其与疾病表型的相关性。
Hum Mol Genet. 1994 Aug;3(8):1303-8. doi: 10.1093/hmg/3.8.1303.
8
Point mutation within the tyrosine kinase domain of the RET proto-oncogene in multiple endocrine neoplasia type 2B and related sporadic tumours.2B型多发性内分泌腺瘤及相关散发性肿瘤中RET原癌基因酪氨酸激酶结构域内的点突变。
Hum Mol Genet. 1994 Feb;3(2):237-41. doi: 10.1093/hmg/3.2.237.
9
Mapping the gene for hereditary hyperparathyroidism and prolactinoma (MEN1Burin) to chromosome 11q: evidence for a founder effect in patients from Newfoundland.将遗传性甲状旁腺功能亢进症和泌乳素瘤基因(MEN1Burin)定位到11号染色体q臂:来自纽芬兰患者存在奠基者效应的证据
Am J Hum Genet. 1994 Jun;54(6):1060-6.
10
Specific mutations of the RET proto-oncogene are related to disease phenotype in MEN 2A and FMTC.RET原癌基因的特定突变与2A型多发性内分泌腺瘤病(MEN 2A)和家族性甲状腺髓样癌(FMTC)的疾病表型相关。
Nat Genet. 1994 Jan;6(1):70-4. doi: 10.1038/ng0194-70.